【作者】 刘鸿； 陆新浩； 朱梦代； 任祖伊； 吴国栋；

【Author】 Liu Hong,Lu Xinhao, Zhu Mengdai, Ren Zuyi, Wu Guodang(Zhejiang Yuyao Research Institute of Poultry Disease Control, Yuyao 315400)

【机构】 浙江省余姚市禽病防治研究所；

【摘要】 由鸭疫里默氏杆菌引起的鸭传性浆膜炎(俗称“三包病”)是当前危害养鸭生产的重大疾病之一。通过实验室药敏试验筛选,并经反复研制成“三包病治疗剂”,并在门诊部扩大临床应用的基础上.先后在宁波、台州、绍兴等13个县市1183群2296990羽发病鸭群临诊应用的反馈统计.防治有效率为96.35%,为农户挽回经济损失1592万元.优于其它抗菌药物,并具有疗效高、成本低、使用方便、无副作用等特点.为基层一线临床兽医和养鸭户解决了一大难题。更多还原

【Abstract】 Duck infectious serositis, also called "Sanbaobing disease" in China,is caused by Riemerella anatipestifer. It becomes one of the most important duck diseases in recent years. "Sanbaobing Pharmaceutics" was studied and produced by drug susceptibility test in laboratory. On the basis of treating test in our poultry diseases clinics, this drug was used for treating 1183 diseased flocks with 2. 3 million ducks in Ningbo, Taizhou, Shaoxing areas and other 13 counties. The recovery rate of treatment was up to 96. 35%. It was estimated that 15. 92 million RMB yuan was saved by reducing economic losses for farmers. Comparing with other antibiotics, "Sanbaobing Pharmaceutics" has properties of better treatment efficiency, lower cost, more convenient application and no side effect. It is concluded that this medicine provide an useful tool for dealing with duck serositis to veterinarians and farmers.更多还原